Back to search
FDAFDA · Food and drugs·Recall number D-0849-2026

0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made in USA, NDC 0338-0049-03

Published September 9, 2026 · Recall initiated: August 17, 2026

Summary

FDA records drug Class I recall D-0849-2026, published September 9, 2026 and initiated August 17, 2026. Recalling firm: Baxter Healthcare Corporation; Status: Ongoing; Reported quantity: 145,464 500mL bags; Lot: Lot: Y495523, Y495523A, Exp 31-Oct-2027. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of particulate matter: Particulates identified as fiberglass

What to do

Voluntary: Firm initiated · Letter

Get an email if SODIUM CHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SODIUM CHLORIDE
Manufacturer
Baxter Healthcare Corporation
Distributor
Natonwide in the USA
Lot
Lot: Y495523, Y495523A, Exp 31-Oct-2027
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made in USA, NDC 0338-0049-03 recalled?

Yes. FDA published recall D-0849-2026 on September 9, 2026. Reported hazard: Presence of particulate matter: Particulates identified as fiberglass

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SODIUM CHLORIDE.